Publications - Donald W . Northfelt, M.D.

Back to Research Profile

1. Curtis KK, Hartney JT, Jewell RC, Park JW, Lebowitz PF, Griffin PP, Borad MJ, Fitch TR, Northfelt DW. A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m2 Administered Weekly as a 30-Minute Intravenous Infusion in Patients With Cancer. J Clin Pharmacol 2009 Oct 06. [Epub ahead of print]
   View PubMed
2. Tan WW, Hillman DW, Salim M, Northfelt DW, Anderson DM, Stella PJ, Niedringhaus R, Bernath AM, Gamini SS, Palmieri F, Perez EA. N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. Ann Oncol 2009 Jul 22. [Epub ahead of print]
   View PubMed
3. Kearns AE, Northfelt DW, Dueck AC, Atherton PJ, Dakhil SR, Rowland KM Jr, Fuloria J, Flynn PJ, Dentchev T, Loprinzi CL. Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer 2009 May 27. [Epub ahead of print]
   View PubMed
4. Cheville AL, Sloan JA, Northfelt DW, Jillella AP, Wong GY, Bearden Iii Jd, Liu H, Schaefer PL, Marchello BT, Christensen BJ, Loprinzi CL. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer 2009 Apr; 17(4):451-60. Epub 2009 Jan 13.
   View PubMed
5. Curtis KK, Connolly MK, Northfelt DW. Live, attenuated varicella zoster vaccination of an immunocompromised patient. J Gen Intern Med 2008 May; 23(5):648-9. Epub 2008 Feb 20.
   View PubMed
6. Okuno SH, Delaune R, Sloan JA, Foster NR, Maurer MJ, Aubry MC, Rowland KM Jr, Soori GS, Nikcevich DA, Kardinal CG, Northfelt DW, Adjei AA, North Central Cancer Treatment Group. A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. Cancer 2008 Apr 15; 112(8):1772-9.
   View PubMed
7. Okuno SH, Delaune R, Sloan JA, Foster NR, Maurer MJ, Aubry MC, Rowland KM Jr, Soori GS, Nikcevich DA, Kardinal CG, Northfelt DW, Adjei AA. A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. Cancer 2008 Apr 15; 112(8):1772-9.
   View PubMed
8. Kelly SV, Burke RF, Lee KS, Torloni AS, Lee RW, Northfelt D, Fonseca R. Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man. Clin Adv Hematol Oncol 2008 Feb; 6(2):133-6.
   View PubMed
9. Sengupta PP, Northfelt DW, Gentile F, Zamorano JL, Khandheria BK. Trastuzumab-induced cardiotoxicity: heart failure at the crossroads. Mayo Clin Proc 2008 Feb; 83(2):197-203.
   View PubMed
10. Curtis KK, Northfelt DW. Patients seeking second medical hematology/oncology opinions in the United States: a report of their demographics and disease processes. Commun Oncol 2007; 4:151-154.
    View PubMed
11. Udhrain A, Skubitz KM, Northfelt DW. Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma. Int J Nanomedicine 2007; 2(3):345-52.
    View PubMed
12. Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006 Jul 15; 65(4):1106-11. Epub 2006 May 26.
    View PubMed
13. Mandrekar SJ, Northfelt DW, Schild SE, Foster NR, Bot B, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Adjei AA, Jett JR. Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials. J Thorac Oncol 2006 Jul; 1(6):556-63.
    View PubMed
14. Hunt KS, Northfelt DW. Incorporating genetic counseling into primary care practice. Resident & Staff Physician 2006 Apr; 52(4):36-42.
    View PubMed
15. Chong G, Bhatnagar A, Cunningham D, Cosgriff TM, Harper PG, Steward W, Bridgewater J, Moore M, Cassidy J, Coleman R, Coxon F, Redfern CH, Jones JJ, Hawkins R, Northfelt D, Sreedharan S, Valone F, Carmichael J. Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol 2006 Mar; 17(3):437-42. Epub 2005 Nov 25.
    View PubMed
16. Curtis KK, Northfelt DW. 74-year-old woman with dyspnea on exertion and anemia. Mayo Clin Proc 2006 Mar; 81(3):393-6.
    View PubMed
17. Campbell NE, Garvey PB, Northfelt DW, Leighton JA, Heppell JP. Management of severe gastrointestinal bleeding in a patient with acquired Von Willebrand disease complicating enteropathic-associated T-cell lymphoma. Pract Gastroenterol 2006; 30(3):76-8.
18. Harris TJ, Northfelt DW. Chemotherapy error: practical approaches to increasing patient safety. J Patient Safety 2005 Dec; 1(4):215-219.
    View PubMed
19. Krown SE, Northfelt DW, Osoba D, Stewart JS. Use of liposomal anthracyclines in Kaposi's sarcoma. Semin Oncol 2004 Dec; 31(6 Suppl 13):36-52.
    View PubMed
20. Northfelt DW. Cervical and anal neoplasia and HPV infection in persons with HIV infection. Oncology (Huntington) 1994 Jan; 8(1):33-7; discussion 38-40.
    View PubMed
21. Lipsey LR, Northfelt DW. Anogenital neoplasia in patients with HIV infection. Curr Opin Oncol 1993 Sep; 5(5):861-6.
    View PubMed
22. Kahn J, Northfelt D, Volberding P. Chemotherapy for AIDS-associated Kaposi's sarcoma. Oncology (Huntington) 1991 Oct; 5(10):57-63; discussion 64, 67.
    View PubMed